Crestor Sales Data
| Rank 4 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Crestor U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 4 ( 1) |
$1,333,502 | 4.53% | 3,656 | 1.58% |
| Q3 2013 | 5 | $1,275,755 | -1.17% | 3,599 | -11.62% |
| Q2 2013 | 5 ( 1) |
$1,290,913 | -0.37% | 4,072 | -0.83% |
| Q1 2013 | 4 (1) |
$1,295,760 | 1.59% | 4,106 | -2.93% |
| Q4 2012 | 3 | $1,275,483 | 2.41% | 4,230 | 0.88% |
| Q3 2012 | 3 (2) |
$1,245,527 | 10.74% | 4,193 | 3.89% |
| Q2 2012 | 5 (2) |
$1,124,702 | 0.61% | 4,036 | 2.80% |
| Q1 2012 | 7 (1) |
$1,117,904 | 2.35% | 3,926 | -3.70% |
| Q4 2011 | 8 | $1,092,260 | 3.69% | 4,077 | 4.62% |
| Q3 2011 | 8 | $1,053,383 | -1.78% | 3,897 | -0.46% |
| Q2 2011 | 8 (1) |
$1,072,498 | 2.32% | 3,915 | 3.35% |
| Q1 2011 | 7 | $1,048,141 | n/a | 3,788 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
